Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-20-001119
Filing Date
2020-04-16
Accepted
2020-04-16 17:00:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d07216enz_04162020.htm SC 13D 156954
2 JOINT FILING AGREEMENT ex991to13d07216enz_04162020.htm EX-99.1 9055
  Complete submission text file 0000921895-20-001119.txt   167574
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Subject) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-35587 | Film No.: 20796985
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 630 FIFTH AVENUE SUITE 2260 NEW YORK NY 10020
Business Address
COUCHMAN JONATHAN (Filed by) CIK: 0001265094 (see all company filings)

Type: SC 13D